{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:18:26Z","timestamp":1791818306881,"version":"4.3.4"},"reference-count":95,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.seminoncol.2025.152347","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T16:09:57Z","timestamp":1746461397000},"page":"152347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The dual effect of interferon-\u03b3 in acute myeloid leukemia: A narrative review"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0987-1259","authenticated-orcid":false,"given":"Abiy Ayele","family":"Angelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gashaw","family":"Adane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dereje Mengesha","family":"Berta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Elias Chane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negesse","family":"Cherie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mebratu","family":"Tamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisrat Birke","family":"Teketelew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.seminoncol.2025.152347_bib0001","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0002","series-title":"Hematopathology","first-page":"429","article-title":"Acute myeloid leukemia","author":"Arber","year":"2018"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0003","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fonc.2018.00444","article-title":"Acute myeloid leukemia and the bone marrow niche take a closer look","volume":"8","author":"Behrmann","year":"2018","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152347_bib0004","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41568-020-0260-3","article-title":"Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis","volume":"20","author":"Yamashita","year":"2020","journal-title":"Nature Rev Cancer"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152347_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4236\/ojbd.2015.53004","article-title":"Detection of pancytopenia associated with clinical manifestation and their final diagnosis","volume":"5","author":"Azaad","year":"2015","journal-title":"Open J Blood Dis"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0006","series-title":"Illustrated pathology of the bone marrow","author":"Orazi","year":"2006"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152347_bib0007","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevImmunol.2014010604","article-title":"NK cells and their ability to modulate T cells during virus infections","volume":"34","author":"Cook","year":"2014","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0008","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1590\/S0074-02762005000900024","article-title":"The role of interferon-gamma on immune and allergic responses","volume":"100","author":"Teixeira","year":"2005","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0009","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cytogfr.2016.07.005","article-title":"The untold story of IFN-\u03b3 in cancer biology","volume":"31","author":"Kursunel","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152347_bib0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","article-title":"Emerging agents and regimens for AML","volume":"14","author":"Liu","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152347_bib0011","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/bjh.13409","article-title":"Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics","volume":"170","author":"Falini","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152347_bib0012","doi-asserted-by":"crossref","first-page":"33","DOI":"10.12968\/hmed.2019.80.1.33","article-title":"Haematopoietic stem cell transplants: principles and indications","volume":"80","author":"Balassa","year":"2019","journal-title":"Br J Hospital Med"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0013","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jcpo.2015.05.002","article-title":"Health-care related supportive-care factors may be responsible for poorer survival of cancer patients in developing countries","volume":"5","author":"Kumar","year":"2015","journal-title":"J Cancer Policy"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0014","first-page":"73","article-title":"Midostaurin: an emerging treatment for acute myeloid leukemia patients","author":"Gallogly","year":"2016","journal-title":"J Blood Med"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.05.002","article-title":"Cellular therapy for acute myeloid leukemia\u2013current status and future prospects","volume":"37","author":"Hansrivijit","year":"2019","journal-title":"Blood Rev"},{"issue":"50","key":"10.1016\/j.seminoncol.2025.152347_bib0016","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1038\/s41388-023-02874-5","article-title":"Low doses of IFN-\u03b3 maintain self-renewal of leukemia stem cells in acute myeloid leukemia","volume":"42","author":"Xie","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0017","unstructured":"Marsico, P., The effects of targeted therapy on cell viability and apoptosis on CML and AML cell lines. 2019."},{"key":"10.1016\/j.seminoncol.2025.152347_bib0018","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00262-006-0159-1","article-title":"Effects of interferon gamma on native human acute myelogenous leukaemia cells","volume":"56","author":"Ersvaer","year":"2007","journal-title":"Cancer Immunol Immunother"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152347_bib0019","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41408-021-00584-3","article-title":"Differentiation therapy for myeloid malignancies: beyond cytotoxicity","volume":"11","author":"Stubbins","year":"2021","journal-title":"Blood Cancer Journal"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152347_bib0020","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000510980","article-title":"Current understandings of myeloid differentiation inducers in leukemia therapy","volume":"144","author":"Takahashi","year":"2021","journal-title":"Acta haematologica"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152347_bib0021","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejca.2009.10.013","article-title":"Redefining the role of interferon in the treatment of malignant diseases","volume":"46","author":"Bracarda","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0022","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s10875-013-9877-2","article-title":"A VEGFR-3 antagonist increases IFN-\u03b3 expression on low functioning NK cells in acute myeloid leukemia","volume":"33","author":"Lee","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.606489","article-title":"The role of structure in the biology of interferon signaling","volume":"11","author":"Walter","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0024","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.fsi.2019.04.002","article-title":"Insights into teleost interferon-gamma biology: an update","volume":"90","author":"Pereiro","year":"2019","journal-title":"Fish Shellfish Immunol"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152347_bib0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5306\/wjco.v15.i2.195","article-title":"Deregulation of interferon-gamma receptor 1 expression and its implications for lung adenocarcinoma progression","volume":"15","author":"Tecalco-Cruz","year":"2024","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113683","article-title":"Role of interferon-gamma (IFN-\u03b3) and IFN-\u03b3 receptor 1\/2 (IFN\u03b3R1\/2) in regulation of immunity, infection, and cancer development: iFN-\u03b3-dependent or independent pathway","volume":"155","author":"Ding","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152347_bib0027","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/ph3020406","article-title":"Deregulation of interferon signaling in malignant cells","volume":"3","author":"Katsoulidis","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0028","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fonc.2017.00265","article-title":"Inflammatory signaling pathways in preleukemic and leukemic stem cells","volume":"7","author":"Hemmati","year":"2017","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152347_bib0029","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/s12015-022-10349-5","article-title":"Leukemic stem cell signatures in acute myeloid leukemia-targeting the Guardians with novel approaches","volume":"18","author":"Thakral","year":"2022","journal-title":"Stem Cell Rev Rep"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152347_bib0030","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3390\/cancers12071760","article-title":"MHC class I downregulation in cancer: underlying mechanisms and potential targets for cancer immunotherapy","volume":"12","author":"Cornel","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0031","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00262-011-1050-2","article-title":"Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands","volume":"60","author":"Sanchez-Correa","year":"2011","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152347_bib0032","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.leu.2404613","article-title":"Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia","volume":"21","author":"Rhein","year":"2007","journal-title":"Leukemia"},{"issue":"26","key":"10.1016\/j.seminoncol.2025.152347_bib0033","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood.2023019961","article-title":"Escape from T-cell\u2013targeting immunotherapies in acute myeloid leukemia","volume":"143","author":"Vadakekolathu","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0034","unstructured":"Linnea, K., NK cell recognition of malignant cells-a CRISPR approach to define novel mediators. 2024."},{"issue":"24","key":"10.1016\/j.seminoncol.2025.152347_bib0035","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.3390\/cancers13246259","article-title":"Identification of potential prognostic and predictive immunological biomarkers in patients with stage I and stage III non-small cell lung cancer (NSCLC): a prospective exploratory study","volume":"13","author":"Vaes","year":"2021","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152347_bib0036","first-page":"10595","article-title":"The relationship of serum levels of gamma interferon and its receptor (CD119) to development of BCG axillary lymphadenopathy","volume":"7","author":"Zamani","year":"2019","journal-title":"Int J Pediatr"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152347_bib0037","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1034\/j.1398-9995.1999.00099.x","article-title":"Biologic functions of the IFN-\u03b3 receptors","volume":"54","author":"Tau","year":"1999","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152347_bib0038","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.3390\/ijms24065377","article-title":"Choosing the right cell line for acute myeloid leukemia (AML) research","volume":"24","author":"Skopek","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0039","unstructured":"Ersv\u00e6r, E., Immunological aspects of acute myelogenous leukemia. 2007."},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152347_bib0040","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1158\/2159-8290.CD-22-0528","article-title":"Senescence rewires microenvironment sensing to facilitate antitumor immunity","volume":"13","author":"Chen","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0041","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.critrevonc.2016.04.020","article-title":"Harnessing the immune system in acute myeloid leukaemia","volume":"103","author":"Austin","year":"2016","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"20","key":"10.1016\/j.seminoncol.2025.152347_bib0042","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1182\/bloodadvances.2020002512","article-title":"TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML","volume":"4","author":"Vadakekolathu","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152347_bib0043","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/sji.12329","article-title":"Clinical role of human leukocyte antigen in health and disease","volume":"82","author":"Mosaad","year":"2015","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0044","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3389\/fimmu.2017.00832","article-title":"Human leukocyte antigen (HLA) and immune regulation: how do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections?","volume":"8","author":"Crux","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0045","unstructured":"Jalili, A., Dendritic cells and their role in cancer immunotherapy. 2007."},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152347_bib0046","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0301-472X(99)00143-5","article-title":"Expression and induction of costimulatory and adhesion molecules on acute myeloid leukemic cells: implications for adoptive immunotherapy","volume":"28","author":"Brouwer","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0047","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3389\/fonc.2019.01004","article-title":"Chemotherapy-induced tumor cell death at the crossroads between immunogenicity and immunotolerance: focus on acute myeloid leukemia","volume":"9","author":"Ocadlikova","year":"2019","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152347_bib0048","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3390\/cancers13061203","article-title":"Immunosuppressive cell subsets and factors in myeloid leukemias","volume":"13","author":"Swatler","year":"2021","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152347_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2000117","article-title":"STAT2 is a pervasive cytokine regulator due to its inhibition of STAT1 in multiple signaling pathways","volume":"14","author":"Ho","year":"2016","journal-title":"PLoS Biol"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0050","unstructured":"Kolosenko, I., Therapeutic response in human cancers: the dual role of STAT signalling. 2016."},{"key":"10.1016\/j.seminoncol.2025.152347_bib0051","article-title":"Pathogenic and therapeutic roles of cytokines in acute myeloid leukemia","volume":"142","author":"Sariani","year":"2021","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152347_bib0052","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.3390\/ijms19123950","article-title":"Bcl-2 inhibition to overcome resistance to chemo-and immunotherapy","volume":"19","author":"Garc\u00eda-Aranda","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152347_bib0053","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/s41467-018-07551-w","article-title":"Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia","volume":"9","author":"Tron","year":"2018","journal-title":"Nature Commun"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152347_bib0054","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41467-024-45916-6","article-title":"Comprehensive characterization of ifn\u03b3 signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies","volume":"15","author":"Wang","year":"2024","journal-title":"Nature Commun"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152347_bib0055","doi-asserted-by":"crossref","DOI":"10.4161\/jkst.26102","article-title":"STAT5 acetylation: mechanisms and consequences for immunological control and leukemogenesis","volume":"2","author":"Kosan","year":"2013","journal-title":"JAK-STAT"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.599933","article-title":"Acute myeloid leukemia: from biology to clinical practices through development and pre-clinical therapeutics","volume":"10","author":"Roussel","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0057","series-title":"Genetic modification and effector functions of natural killer cells in acute myeloid leukemia","author":"Siegler","year":"2006"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0058","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cytogfr.2018.08.004","article-title":"The cytokine network in acute myeloid leukemia (AML): a focus on pro-and anti-inflammatory mediators","volume":"43","author":"Binder","year":"2018","journal-title":"Cytokine & growth factor reviews"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0059","series-title":"Regulation of cytokine signaling during macrophage differentiation and activation","author":"Junttila","year":"2005"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152347_bib0060","first-page":"416","article-title":"Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities","volume":"88","author":"Bruserud","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0061","series-title":"Role of the hematopoietic corepressor CBFA2T3 in acute myeloid leukemia","author":"Steinauer","year":"2020"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0062","unstructured":"Reikvam, H., New therapeutic targets in human acute myeloid leukemia. 2012."},{"key":"10.1016\/j.seminoncol.2025.152347_bib0063","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s12185-017-2184-6","article-title":"Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment","volume":"105","author":"Camacho","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1000996","article-title":"The cytokine network in acute myeloid leukemia","volume":"13","author":"Luciano","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152347_bib0065","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1189\/jlb.3RU0316-144R","article-title":"Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage","volume":"100","author":"Ushach","year":"2016","journal-title":"J Leucocyte Biol"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.772408","article-title":"Inflammatory cytokines shape an altered immune response during myeloid malignancies","volume":"12","author":"Camacho","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152347_bib0067","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.humimm.2020.01.004","article-title":"The pro-inflammatory cytokines effects on mobilization, self-renewal and differentiation of hematopoietic stem cells","volume":"81","author":"Jahandideh","year":"2020","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152347_bib0068","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/cdd.2014.89","article-title":"Regulation of hematopoietic and leukemic stem cells by the immune system","volume":"22","author":"Riether","year":"2015","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0069","first-page":"194","article-title":"Cytokine expression and signaling in brain tumors","volume":"2","author":"Dey","year":"2005","journal-title":"Cytokines and the CNS"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152347_bib0070","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nature Rev Clin Oncol"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152347_bib0071","doi-asserted-by":"crossref","first-page":"e1291","DOI":"10.1002\/cnr2.1291","article-title":"Molecular and cellular paradigms of multidrug resistance in cancer","volume":"5","author":"Vaidya","year":"2022","journal-title":"Cancer Rep"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152347_bib0072","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48256-4","article-title":"Myeloid maturation potentiates STAT3-mediated atypical IFN-\u03b3 signaling and upregulation of PD-1 ligands in AML and MDS","volume":"9","author":"Yoyen-Ermis","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152347_bib0073","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1586\/17474086.2014.958464","article-title":"The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment","volume":"7","author":"Isidori","year":"2014","journal-title":"Exp Rev Hematol"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0074","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1023\/B:APPT.0000045788.61012.b2","article-title":"The inhibitor of apoptosis protein family and its antagonists in acute leukemias","volume":"9","author":"Wrzesie\u0144-Ku\u015b","year":"2004","journal-title":"Apoptosis"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152347_bib0075","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1182\/blood-2003-07-2490","article-title":"Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies","volume":"104","author":"Mahadevan","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152347_bib0076","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.3390\/ijms22052470","article-title":"Oxidative stress and ROS-mediated signaling in leukemia: novel promising perspectives to eradicate chemoresistant cells in myeloid leukemia","volume":"22","author":"Trombetti","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152347_bib0077","article-title":"PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway","volume":"12","author":"Wang","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152347_bib0078","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI12807","article-title":"Therapeutic targeting of the MEK\/MAPK signal transduction module in acute myeloid leukemia","volume":"108","author":"Milella","year":"2001","journal-title":"J Clin Investig"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0079","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fphar.2019.00609","article-title":"A review of efficacy and safety of checkpoint inhibitor for the treatment of acute myeloid leukemia","volume":"10","author":"Liao","year":"2019","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152347_bib0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2022.280800","article-title":"Leukemic stem cells and therapy resistance in acute myeloid leukemia","volume":"108","author":"Stelmach","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115007","article-title":"Pretreatment of umbilical cord derived MSCs with IFN-\u03b3 and TNF-\u03b1 enhances the tumor-suppressive effect on acute myeloid leukemia","volume":"199","author":"Sun","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0082","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1182\/blood-2018-99-112497","article-title":"Up-regulation of immune tolerance genes in leukemic mesenchymal stromal cells is induced by acute myeloid leukemia cells through an IFN-gamma-dependent inflammatory signaling","volume":"132","author":"Ciciarello","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0083","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1182\/blood-2019-126512","article-title":"Interferon-\u03b3-dependent inflammatory signature in acute myeloid leukemia cells is able to shape stromal and immune bone marrow microenvironment","volume":"134","author":"Ciciarello","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152347_bib0084","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/14728222.2017.1300255","article-title":"Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism","volume":"21","author":"Brenner","year":"2017","journal-title":"Exp Opin Therap Targets"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152347_bib0085","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s12015-021-10308-6","article-title":"Acute myeloid leukemia stem cells: origin, characteristics, and clinical implications","volume":"18","author":"Long","year":"2022","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152347_bib0086","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41419-023-05728-w","article-title":"Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients","volume":"14","author":"Holicek","year":"2023","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0087","series-title":"Investigation of the role of bone marrow stromal cells in the microenvironment of acute myeloid leukaemia","author":"Abdul-Aziz","year":"2017"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0088","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.659253","article-title":"Escape from treatment; the different faces of leukemic stem cells and therapy resistance in acute myeloid leukemia","volume":"11","author":"Van Gils","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0089","unstructured":"Michelozzi, I., The role of the bone marrow microenvironment in aplastic anaemia and acute myeloid leukaemia: from pathogenesis to chemoresistance. 2019."},{"key":"10.1016\/j.seminoncol.2025.152347_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-6-74","article-title":"The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies","volume":"6","author":"Shi","year":"2013","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152347_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.152049","article-title":"The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expression","volume":"226","author":"Antohe","year":"2021","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.seminoncol.2025.152347_bib0092","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2174\/156800911796191024","article-title":"Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer","volume":"11","author":"Goedegebuure","year":"2011","journal-title":"Current Cancer Drug Targets"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0093","series-title":"Interferon-\u03b3 modulates intestinal P-glycoprotein: molecular mechanism and clinical implications","author":"Dixit","year":"2005"},{"key":"10.1016\/j.seminoncol.2025.152347_bib0094","series-title":"An overview of acute myeloid leukemia and cancer Immunology:(i) concepts and therapeutic strategies and (ii) repsox as a candidate cell-engineering tool","author":"Jajosky","year":"2014"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152347_bib0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imbio.2015.07.012","article-title":"Tricking the balance: NK cells in anti-cancer immunity","volume":"222","author":"Pahl","year":"2017","journal-title":"Immunobiology"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425000399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425000399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T16:50:39Z","timestamp":1750870239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775425000399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0093775425000399"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152347","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dual effect of interferon-\u03b3 in acute myeloid leukemia: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152347"}}